AskTheDate.com
Back to calendar

NewAmsterdam Pharma Company N.V. (NAMS) Earnings

NAMS reports earnings on Wednesday, November 11, 2026

earnings report
November 11, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.50
Actual EPS: $-0.52
Company overview
Market Cap$3.0B
SectorHealth Technology
IndustryPharmaceuticals: Major
Buy me a coffee